Shargeo Kawaguchi
The pursuit of precision medicine has long been a goal. Traditional cancer treatments often used a uniform approach, effective for some but inadequate for many. Yet, technological advances and molecular biomarkers have revolutionized cancer diagnosis and treatment. These molecular signals enable tailored therapies, enhancing outcomes and patient care. Precision oncology is a transformative strategy considering each patient's tumour's unique molecular features. Unlike the old one-size-fits-all approach, it personalizes treatment based on specific genetic changes fuelling tumour progression. By harnessing molecular biomarkers, clinicians can better understand the underlying biology of cancer and identify targeted therapies that offer the greatest chance of success.
この記事をシェアする
English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi 